GLP-1 Medication in Japan: Brands, Import Rules and Access
All GLP-1 medications require a prescription in Japan. Bring your full supply with a doctor's letter and keep injectables in original packaging.
Quick reference
- Drug class: GLP-1 receptor agonists and GLP-1/GIP dual agonists
- Controlled substance: No active ingredient in this class is scheduled under Japan's Narcotics and Psychotropics Control Law. All are prescription-only but not controlled substances.
- Prescription required: Yes. All GLP-1 medications require a Japanese prescription for local dispensing. A foreign prescription cannot be filled directly at a Japanese pharmacy.
- Available locally: Semaglutide: yes (Ozempic, Wegovy, Rybelsus). Tirzepatide: yes (Mounjaro). Liraglutide: yes (Victoza, Saxenda, Xultophy). Dulaglutide: yes (Trulicity). Lixisenatide: yes (Lyxumia). Exenatide: limited or discontinued, verify before travel. Pramlintide: not registered in Japan.
- Storage: Most injectable formulations (Ozempic, Wegovy, Mounjaro, Trulicity, Victoza, Saxenda, Lyxumia) must be kept at 2–8°C before first use. Rybelsus (oral semaglutide) and most opened pens can be kept at room temperature up to 30°C for a limited period, check your specific product's label.
- Max supply to carry: Up to one month's supply may be brought into Japan without an import permit for personal use under the Yakkan Shoumei rules. Quantities above one month require advance MHLW approval.
- Key document: Doctor's letter on clinic letterhead naming the INN, brand name, dose, frequency, and quantity carried. A Yakkan Shoumei (import confirmation) is required if you carry more than one month's supply.
- Emergency alternative: If your specific brand is unavailable, consult a local endocrinologist or diabetes specialist who can assess which registered alternative is appropriate for your situation.
GLP-1 medication options in Japan
| Active ingredient | Available locally? | Local brand(s) | Controlled status | Prescription required? | Max supply (import) |
|---|---|---|---|---|---|
| Semaglutide | Yes | Ozempic, Wegovy, Rybelsus | Not controlled | Yes | 1 month without permit |
| Tirzepatide | Yes | Mounjaro | Not controlled | Yes | 1 month without permit |
| Liraglutide | Yes | Victoza, Saxenda, Xultophy | Not controlled | Yes | 1 month without permit |
| Dulaglutide | Yes | Trulicity | Not controlled | Yes | 1 month without permit |
| Exenatide | Limited, verify | Byetta (verify current status) | Not controlled | Yes | 1 month without permit |
| Lixisenatide | Yes | Lyxumia | Not controlled | Yes | 1 month without permit |
| Pramlintide | No | Not registered in Japan | Not controlled | N/A | Bring full supply |
Taking GLP-1 medication to Japan
Japan has approved semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Victoza, Saxenda, Xultophy), dulaglutide (Trulicity), and lixisenatide (Lyxumia) for clinical use. None of these active ingredients is scheduled under Japan's Narcotics and Psychotropics Control Law, so you do not need a controlled-substance import permit. Each is prescription-only, and a foreign prescription cannot be filled directly at a Japanese pharmacy.
Pramlintide (Symlin) is not registered by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) and is unavailable locally. Exenatide's current registration status in Japan should be confirmed with the PMDA before travel, as marketing has been variable.[1]
Medical disclaimer: This guide is for informational purposes only and does not constitute medical advice. Always consult your prescribing doctor before travelling with medication, particularly regarding supply quantities, storage requirements, and import documentation.
Before you travel
Documentation for travelling to Japan with GLP-1 medication
Japan's Ministry of Health, Labour and Welfare (MHLW) requires that travellers carrying more than a one-month supply of any prescription medication obtain a Yakkan Shoumei (import confirmation certificate) before arrival. For a supply of one month or less, a doctor's letter and original packaging are sufficient. All GLP-1 medications fall under this general prescription-medication import rule. Refer to our diabetes in Japan travel guide for a full documentation checklist.
What your doctor's letter must include
Your full name. Medication name (INN and brand). Dose and frequency. Quantity carried. Diagnosis or condition name. Doctor's signature and registration number. Clinic letterhead with contact details. If you take more than one GLP-1 active ingredient, list each separately on the letter.
Because no GLP-1 active ingredient is a controlled substance in Japan, no Narcotics and Psychotropics Control permit is required for any member of this class. The standard doctor's letter and original pharmacy packaging are the only documents required for a one-month supply.
Questions to ask your prescriber before you travel
Bring this list to your appointment before departing.
- If my specific brand (e.g. Ozempic, Mounjaro, Saxenda) is temporarily unavailable in Japan, which other registered GLP-1 option would you consider appropriate for me, and can you note that in my letter?
- Should my dose or frequency be adjusted for any reason during a long-haul flight or significant time-zone change, and if so, how?
- Can you include both the INN and brand name on my letter, confirm your medical registration number, and write it on official clinic letterhead?
- If my trip exceeds one month, can you arrange a Yakkan Shoumei application or provide a supporting letter for the MHLW process?
- What is the best way to contact you from Japan if I have an urgent clinical question about my medication or need a further letter?
How much GLP-1 medication to bring
The standard personal-import allowance for prescription medication in Japan is one month's supply without a Yakkan Shoumei. This applies to every GLP-1 active ingredient in this class. If your trip exceeds one month, apply for the Yakkan Shoumei through the MHLW at least four to six weeks before departure. Bring a buffer of at least one extra dose cycle in case of travel delays.
Split your supply
Carry your main supply in hand luggage and a backup dose in checked luggage. Keep both in original packaging with pharmacy labels attached. For refrigerated pens, pack the backup in an insulated pouch in your carry-on rather than checked luggage where temperatures can drop unpredictably.
Packing and storing GLP-1 medication for travel
All injectable GLP-1 pens (Ozempic, Wegovy, Mounjaro, Trulicity, Victoza, Saxenda, Lyxumia) must be stored at 2–8°C before first use, consistent with cold-chain medication guidelines.[5] Once opened or in use, most pens tolerate room temperature (up to 30°C) for 4 to 6 weeks, but check your specific product information label. Rybelsus (oral semaglutide) is stored at room temperature and does not need refrigeration.
Use a medical-grade insulated travel case with ice packs for all refrigerated pens during transit. Tokyo's summer temperatures frequently exceed 35°C, so avoid leaving medication in a car or bag left in the sun. Request a mini-bar or fridge in your accommodation before arrival.
At the airport and border
Airport security with GLP-1 medication
All injectable GLP-1 pens and associated sharps (needles, lancets) are exempt from the standard 100 ml liquid restriction in carry-on baggage at most international airports when accompanied by a doctor's letter and pharmacy label. Japan's airport security authority follows the same liquid-medication exemption policy applied at Narita (NRT), Haneda (HND), Kansai (KIX), and other major airports. Present your medication separately at the security checkpoint with your doctor's letter to hand.[2]
Needles and pen devices should be in a sharps case or the original branded pen packaging. If you use a dedicated sharps disposal container, keep it in your carry-on rather than checked luggage to avoid confusion with prohibited items at baggage screening.
Customs and import rules for GLP-1 medication in Japan
Japan Customs and the MHLW allow travellers to bring a personal supply of up to one month of prescription medication without prior import approval. A supply exceeding one month requires a Yakkan Shoumei submitted to the MHLW Regional Bureau before arrival. Declare your medication on the customs form if you are carrying quantities above your personal-use allowance or if asked by a customs officer.
Keep original packaging at all times
No GLP-1 active ingredient is a controlled substance in Japan, so there is no additional permit requirement beyond the standard prescription-medication rules. However, always carry medication in the original manufacturer packaging with the pharmacy dispensing label intact. This confirms the product identity, batch number, and your prescription details to customs officers.
While in country
GLP-1 medication availability in Japan
Semaglutide is available in Japan as Ozempic (injectable), Wegovy (injectable), and Rybelsus (oral tablet). Tirzepatide is sold as Mounjaro. Liraglutide is available as Victoza, Saxenda, and the combination product Xultophy. which are dispensed through hospital and clinic pharmacies with a local prescription.[1]
Dulaglutide is available as Trulicity and lixisenatide as Lyxumia. Exenatide's current registration status in Japan should be verified with PMDA before travel, as Byetta marketing activity has been variable. Pramlintide (Symlin) is not registered in Japan and cannot be obtained locally under any circumstances.[1]
A single consultation with an endocrinologist or diabetologist at a private clinic in Tokyo typically costs ¥3,000–¥8,000 (~$19–$50 / ~€17–€43) before medication costs. Prescription GLP-1 pens at a hospital pharmacy are priced in line with Japan's national drug tariff and are not available at general community pharmacies without a clinic prescription.
Pharmacy phrases in Japanese
Use these phrases at a pharmacy counter or clinic when asking about GLP-1 medication options.
“私はGLP-1の薬を使っています。同じ薬はありますか?”
I take a GLP-1 medication. Do you have an equivalent available?
“オゼンピック(セマグルチド)はありますか?”
Do you have Ozempic (semaglutide)?
“この薬のジェネリックはありますか?”
Is there a generic equivalent for this medication?
Get these phrases in 23 languages — offline
Nomedic Translate works at the pharmacy counter even without signal.
Finding a doctor who can prescribe GLP-1 medication in Japan
Endocrinologists and diabetologists at private hospitals and international clinics in Tokyo, Osaka, and Kyoto can prescribe GLP-1 medications to international patients. Private international clinics in Tokyo charge ¥5,000–¥15,000 (~$32–$95 / ~€28–€81) for an initial consultation. Use Nomedic's provider search to find English-speaking endocrinologists near your destination.[3]
Search for providers near your destination
Use Nomedic's provider search to find doctors and pharmacies in Japan.
Storing GLP-1 medication while in Japan
Most hotels in Tokyo and other major cities have in-room refrigerators. Request one at booking and confirm it reaches 2–8°C, since some hotel mini-bars run at higher temperatures. If your accommodation lacks a fridge, ask the front desk to store your pens in the hotel's kitchen refrigerator. Learn more about cold chain management by reading our GLP-1 travel guide.
Tokyo's summer (June to September) sees temperatures regularly above 35°C. An in-use pen left at room temperature must be used within the product-specific window (typically 4 to 6 weeks at up to 30°C), so monitor ambient temperatures during day trips.[6] Insulated medication wallets available at Japanese pharmacies (yakkyoku) are a practical backup for day travel.
Emergencies
What to do if something goes wrong with your GLP-1 medication in Japan
If your medication is lost or stolen, file a report with local police (dial 110) immediately and obtain a reference number. Japan's MHLW requires the police report as supporting documentation if you need to arrange an emergency replacement through a licensed clinic. Contact your travel insurance emergency assistance line immediately after filing the police report.[4]
If you run out of your specific GLP-1 active ingredient, consult a local endocrinologist rather than attempting a self-directed switch. Semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), and liraglutide (Victoza, Saxenda) are the most reliably stocked GLP-1 options in Japan's major cities.
Key phrases in Japanese
I take medication for diabetes / obesity: 糖尿病/肥満の薬を服用しています (Tounyoubyou/Himan no kusuri wo fukuyou shite imasu). I need a doctor urgently: 急いで医者が必要です (Isoide isha ga hitsuyou desu). Where is the nearest pharmacy?: 近くの薬局はどこですか? (Chikaku no yakkyoku wa doko desu ka?). Please call an ambulance: 救急車を呼んでください (Kyuukyuusha wo yonde kudasai).
Dial 119 for an ambulance in Japan. Emergency departments at major hospitals in Tokyo (such as Tokyo Medical University Hospital) have English-language assistance lines, but having your medication details recorded in your IPS significantly speeds up triage.
Your medication details, ready to share
Nomedic stores your medication name, INN, dosage, and frequency in your IPS, readable by any clinician worldwide.
Frequently asked questions
Is GLP-1 medication legal in Japan?
Yes. All currently registered GLP-1 medications in Japan (semaglutide, tirzepatide, liraglutide, dulaglutide, and lixisenatide) are legal with a valid prescription. None is scheduled under Japan's Narcotics and Psychotropics Control Law. Pramlintide is not registered and cannot be obtained locally, but bringing a personal supply for your own use is permitted under standard prescription-medication import rules.
Can I bring GLP-1 medication into Japan?
Yes, up to a one-month supply can be brought into Japan without prior import approval, provided you carry a doctor's letter and keep medication in original pharmacy packaging. A supply exceeding one month requires a Yakkan Shoumei (import confirmation certificate) obtained from the MHLW before arrival. No controlled-substance permit is required for any GLP-1 medication.
Do I need a doctor's letter to fly with GLP-1 medication?
A doctor's letter is strongly recommended for all injectable GLP-1 pens regardless of quantity, because sharps and refrigerated injectables attract scrutiny at security. For quantities above one month's supply, a doctor's letter forms part of the mandatory Yakkan Shoumei supporting documents for MHLW approval. Without a letter, customs officers may question the quantity or purpose of your medication.
Is Zepbound (tirzepatide) available in Japan?
Zepbound is the US-market brand name for tirzepatide indicated for weight management. In Japan, tirzepatide is registered and sold as Mounjaro. If you take Zepbound at home, Mounjaro contains the same active ingredient, but any dose adjustment or switch must be confirmed by a local prescriber rather than assumed to be equivalent.
Which GLP-1 medications are available in Japan?
Semaglutide is available as Ozempic, Wegovy, and Rybelsus. Tirzepatide is sold as Mounjaro. Liraglutide is sold as Victoza, Saxenda, and Xultophy. Dulaglutide is sold as Trulicity. Lixisenatide is sold as Lyxumia. Exenatide's current status should be verified with the PMDA before travel. Pramlintide is not registered and unavailable locally.
What if I run out of GLP-1 medication in Japan?
Visit a private clinic or hospital with an endocrinology department. Bring your doctor's letter, IPS, and any remaining packaging to show your current active ingredient and dose. The clinician can assess which locally registered GLP-1 option is suitable and issue a Japanese prescription. Community pharmacies (yakkyoku) cannot dispense GLP-1 medications without a local prescription.
What if my specific GLP-1 brand is not available in Japan?
Consult a local endocrinologist rather than switching without medical supervision. Semaglutide and tirzepatide are the most consistently stocked options at hospital pharmacies in Tokyo and Osaka. Bring your IPS or a full medication letter so the clinician has your current dose and indication details before considering any alternative.
Related practical guide
GLP-1 Medications Abroad: Cold Chain Failures, Customs Traps and Approval Gaps
Your Ozempic pen survives the flight but gets confiscated at the border. Here is how cold chain failures, customs rules, and approval gaps catch GLP-1 travellers off guard.
Read the practical guide →Sources
- [1] PMDA (Pharmaceuticals and Medical Devices Agency) — Approved Drug Products Search
- [2] Narita International Airport — Security Screening Information
- [3] Tokyo Medical Information Service — Hospitals and Clinics
- [4] Japan Customs — Procedures for Importing Personal Medicines
- [5] Novo Nordisk Medical — GLP-1 RAs Storage & Stabilty
- [6] Does Ozempic Need to be Refrigerated?
More guides in Japan
- CityTokyo Health Guide
- ConditionDiabetes in Japan: Insulin Import Rules, Summer Heat and Pharmacy Access
- ConditionAutism in Japan: Medication Import Rules, Sensory Environment and Specialist Access
- ConditionAnxiety Disorder in Japan: Benzodiazepine Import Rules, SSRIs and Psychiatrist Access
- ConditionTravelling to Japan in a Wheelchair: Healthcare, Medications and Emergency Protocols
- ConditionTravelling to Japan with ADHD: Medications, Customs Rules and Healthcare
- MedicationAtomoxetine in Japan: Strattera, Import Rules and Availability
- MedicationMetformin in Japan: Brands, Yakkan Shoumei and Pharmacies
- MedicationAdderall in Japan: Stimulants Control Act Ban, ADHD Plan
- MedicationConcerta in Japan: ADHD Status, Shortage and Prescribers
- MedicationRitalin in Japan: Narcolepsy Only, ADHD Delisted in 2007
- MedicationMethylphenidate in Japan: Yakkan Shoumei and Prescribing
- MedicationInsulin in Japan: Brands, Cold Chain and Import Rules
- MedicationAmphetamine / Dextroamphetamine in Japan: Ban, Legal Risk and ADHD Plan
- MedicationBenzodiazepines in Japan: Import Rules, Brands and Permits
- MedicationDexamfetamine in Japan: Stimulants Control Act and Import Rules
- MedicationDexmethylphenidate in Japan: Import Rules and Brands
- MedicationMelatonin in Japan: Import Rules, Brands and Availability
- MedicationVyvanse in Japan: Stimulants Control Act, Children-Only Approval and NCD Permits
- MedicationXanax in Japan: Controlled Status, Supply and Prescribers